Bayesian Capital Management, LP Qiagen N.V. Transaction History

Bayesian Capital Management, LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$35.55 - $43.57 $206,509 - $253,098	5,809 Added 23.06%	31,000 $1.35 Million
Q3 2023 Nov 14, 2023	BUY	$39.13 - $47.24 $333,974 - $403,193	8,535 Added 51.24%	25,191 $1.02 Million
Q2 2023 Aug 14, 2023	BUY	$43.93 - $46.76 $731,698 - $778,834	16,656 New	16,656 $750,000
Q4 2022 Feb 14, 2023	BUY	$41.91 - $50.48 $360,425 - $434,128	8,600 Added 131.1%	15,160 $756,000
Q3 2022 Nov 14, 2022	BUY	$40.9 - $50.42 $61,309 - $75,579	1,499 Added 29.62%	6,560 $271,000
Q2 2022 Aug 15, 2022	SELL	$42.98 - $49.77 $764,270 - $885,010	-17,782 Reduced 77.84%	5,061 $239,000
Q1 2022 May 16, 2022	BUY	$42.23 - $54.3 $964,659 - $1.24 Million	22,843 New	22,843 $1.12 Million
Q3 2020 Nov 12, 2020	SELL	$42.51 - $52.42 $255,060 - $314,520	-6,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$39.49 - $44.36 $487,543 - $547,668	-12,346 Reduced 67.3%	6,000 $257,000
Q1 2020 May 15, 2020	BUY	$33.17 - $41.6 $608,536 - $763,193	18,346 New	18,346 $763,000
Q2 2019 Aug 13, 2019	SELL	$35.73 - $41.39 $269,618 - $312,328	-7,546 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$33.78 - $40.68 $1.34 Million - $1.62 Million	-39,800 Reduced 84.06%	7,546 $307,000
Q4 2018 Feb 13, 2019	BUY	$32.65 - $37.95 $496,737 - $577,371	15,214 Added 47.35%	47,346 $1.63 Million
Q3 2018 Nov 14, 2018	BUY	$35.99 - $39.39 $756,941 - $828,450	21,032 Added 189.48%	32,132 $1.22 Million
Q2 2018 Aug 14, 2018	BUY	$31.23 - $37.47 $346,653 - $415,917	11,100 New	11,100 $401,000

6.37M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.5B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.